Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03BNC
|
||||
| Former ID |
DNC011416
|
||||
| Drug Name |
HI-240
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C14H13BrFN3S
|
||||
| Canonical SMILES |
C1=CC=C(C(=C1)CCNC(=S)NC2=NC=C(C=C2)Br)F
|
||||
| InChI |
1S/C14H13BrFN3S/c15-11-5-6-13(18-9-11)19-14(20)17-8-7-10-3-1-2-4-12(10)16/h1-6,9H,7-8H2,(H2,17,18,19,20)
|
||||
| InChIKey |
MIJLSRZJDIBHJU-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | HIV-1 reverse transcriptase | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 1999 Dec 20;9(24):3411-6.N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.